Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

CPAMD8 Activators

CPAMD8 can engage in a variety of signaling cascades to promote the functional activation of this protein. Acetylcholine, for instance, is known to activate muscarinic and nicotinic receptors, leading to downstream signaling pathways that involve calcium influx. This increase in intracellular calcium can subsequently activate CPAMD8. Similarly, pilocarpine and carbachol, both muscarinic acetylcholine receptor agonists, stimulate signaling cascades that elevate intracellular calcium levels, potentially resulting in the activation of CPAMD8. Nicotine, by binding to nicotinic acetylcholine receptors, also causes an increase in intracellular calcium, which could lead to the downstream activation of CPAMD8. Histamine, by activating its G protein-coupled receptors, can stimulate phospholipase C, leading to a rise in inositol trisphosphate and diacylglycerol, second messengers that may be involved in the activation of CPAMD8. Bradykinin, through its interaction with B2 receptors, can initiate a similar phospholipase C-mediated pathway, which may also contribute to the activation of CPAMD8.

forskolin and IBMX both function to elevate intracellular cAMP levels, with forskolin directly activating adenylate cyclase and IBMX inhibiting phosphodiesterases that degrade cAMP. The resultant increase in cAMP can lead to protein kinase A (PKA) activation, which may then phosphorylate CPAMD8, leading to its activation. Likewise, vasoactive intestinal peptide (VIP) activates its G protein-coupled receptors, potentially resulting in increased cAMP and subsequent PKA activation, which could phosphorylate and activate CPAMD8. Epinephrine and norepinephrine bind to adrenergic receptors and can also cause a rise in cAMP levels, potentially leading to PKA-mediated phosphorylation and activation of CPAMD8. Serotonin, through its diverse array of receptors, leads to a multitude of downstream effects, including the activation of second messenger systems such as cAMP, which could culminate in the activation of CPAMD8 through these complex intracellular signaling networks.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

IBMX increases intracellular cAMP by inhibiting phosphodiesterases, potentially leading to PKA activation and phosphorylation of CPAMD8.

Pilocarpine

92-13-7sc-479256
100 mg
$255.00
1
(0)

Pilocarpine, a muscarinic acetylcholine receptor agonist, can stimulate a signaling cascade that may lead to activation of CPAMD8 through increased intracellular calcium.

Carbachol

51-83-2sc-202092
sc-202092A
sc-202092C
sc-202092D
sc-202092B
sc-202092E
1 g
10 g
25 g
50 g
100 g
250 g
$122.00
$281.00
$388.00
$683.00
$1428.00
$3060.00
12
(2)

Carbachol activates cholinergic receptors, which could result in the activation of CPAMD8 by altering intracellular calcium levels and modulating downstream effectors.

Histamine, free base

51-45-6sc-204000
sc-204000A
sc-204000B
1 g
5 g
25 g
$94.00
$283.00
$988.00
7
(1)

Histamine, through its G protein-coupled receptors, can activate phospholipase C, increasing inositol trisphosphate and diacylglycerol, which may activate CPAMD8.

(−)-Epinephrine

51-43-4sc-205674
sc-205674A
sc-205674B
sc-205674C
sc-205674D
1 g
5 g
10 g
100 g
1 kg
$41.00
$104.00
$201.00
$1774.00
$16500.00
(1)

Epinephrine binds to adrenergic receptors, leading to adenylate cyclase activation, increased cAMP, and potential PKA-mediated activation of CPAMD8.

L-Noradrenaline

51-41-2sc-357366
sc-357366A
1 g
5 g
$326.00
$485.00
3
(0)

Norepinephrine engages adrenergic receptors, which might lead to cAMP accumulation and activation of CPAMD8 through PKA-dependent phosphorylation.

Bradykinin

58-82-2sc-507311
5 mg
$110.00
(0)

Bradykinin binds to B2 receptors, which may lead to the activation of phospholipase C and subsequent signaling cascades that activate CPAMD8.

3-(2-Aminoethyl)-1H-indol-5-ol

50-67-9sc-298707
1 g
$530.00
3
(0)

Serotonin interacts with its receptors, leading to various downstream effects, including potential activation of CPAMD8 through second messenger systems like cAMP.